In the title compound, C(18)H(17)BrN(2)O(2), which is a potential -human immunodeficiency virus type 1 (HIV-1) non-nucleoside reverse transcriptase inhibitor, the pyrrolidine ring exhibits an envelope conformation. In the crystal structure, inter-molecular N-H⋯O hydrogen bonds [N⋯O = 2.861 (3) Å] link the mol-ecules into centrosymmetric dimers.